
Cytarabine - Wikipedia
Cytarabine, also known as cytosine arabinoside (ara-C), is a chemotherapy medication used to treat acute myeloid leukemia (AML), acute lymphocytic leukemia (ALL), chronic myelogenous leukemia (CML), and non-Hodgkin's lymphoma. [2]
Cytarabine, ARA-C injection - Cleveland Clinic
CYTARABINE, ARA-C (sye TARE a been) is a chemotherapy drug. This medicine reduces the growth of cancer cells and can suppress the immune system. It is used for treating leukemias or lymphomas.
Cytarabine (Ara C, cytosine arabinoside) - Cancer Research UK
Cytarabine (Ara C, cytosine arabinoside) Cytarabine is a type of chemotherapy. It is also known as Ara C or cytosine arabinoside. You pronounce cytarabine sye-ta-ra-bin. It is a treatment for: acute leukaemias (cancers of the blood) some lymphomas (cancers of the lymph glands)
Ara-C - Chemocare
CYTARABINE (sye TARE a been) treats leukemia. It works by slowing down the growth of cancer cells. This medicine may be used for other purposes; ask your health care provider or pharmacist if you have questions. What should I tell my care team before I take this medication? This medication is injected into a vein or under the skin.
Cytarabine Dose for Acute Myeloid Leukemia | New England ...
2011年3月17日 · Cytarabine (ara-C) is an important drug in the treatment of acute myeloid leukemia (AML). High-dose cytarabine (2000 to 3000 mg per square meter of body-surface area) is toxic but results in...
HiDAC for AML (Acute Myeloid Leukemia) | ChemoExperts
HiDAC (High Dose Ara-C) is a Chemotherapy Regimen for Acute Myeloid Leukemia (AML) How does Hidac chemotherapy work? Hi gh D ose A ra -C , also known as "HiDAC," is designed to kill the remaining cancer cells after induction chemotherapy is completed.
Cytarabine (Ara-C) | HemOnc.org - A Hematology Oncology Wiki
Class/mechanism: Pyrimidine analog, mimics cytosine. Converted intracellularly into cytarabine-5-triphosphate (ara-CTP). Exact mechanism of action not known; believed to inhibit DNA polymerase, incorporate into DNA and RNA, and kill cells undergoing DNA synthesis (S-phase) and sometimes block cells from progressing from the G1 phase to the S-phase.
Cytarabine (Cytosar-U®, Ara-C, DepoCyt®) - OncoLink
2023年8月17日 · Cytarabine affects the DNA of cells. How it works is not clearly understood, but it seems to affect DNA polymerase (an important enzyme in DNA synthesis). Because cells cannot copy their DNA, they cannot properly divide, causing the cancer cells to die.
Ara-C: Uses, Dosage, Side Effects, Food Interaction & FAQ
2025年1月7日 · Ara-C is an antineoplastic anti-metabolite used in the treatment of several forms of leukemia including acute myelogenous leukemia and meningeal leukemia. Anti-metabolites masquerade as purine or pyrimidine - which become the building blocks of DNA.
Cytarabine (Ara C.cytosine arabinoside) - CANCERactive
2018年7月27日 · This patient-friendly article is about chemotherapy drug, Cytarabine (Ara C.cytosine arabinoside) which is mostly used for the treatment of acute myeloid leukaemia (AML), non-Hodgkin’s lymphoma and some head and neck cancers.
- 某些结果已被删除